Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Western blot analysis of EP300 was performed with 10 µg of HeLa cells transfected with Transfection Reagent alone (Lane 1), 100nM Non-Targeting control siRNA (Lane 2), or 100nM siRNA against EP300 (Lane 3). Proteins were resolved using a NuPAGE® Novex 4-12% Bis-Tris Gel (NP0322BOX), XCell SureLock™ Electrophoresis System (EI0002), and a protein size ladder. Proteins were wet transferred to a Pierce Nitrocellulose Membrane (Product # 88025) OR Pierce PVDF Membrane (Product # 88518) and blocked with Pierce Starting Block T20 (PBS) Blocking Buffer (37539) for 1 hour at room temperature. EP300 was detected at ~ 300 kDa using EP300 Mouse monoclonal antibody (Product # MA1-16608) diluted in Pierce Starting Block T20 (PBS) Blocking Buffer 4°C overnight on a rocking platform. Pierce Goat Anti-Mouse (product # 031437) HRP-Conjugated Antibodies at a 1:2500 dilution were used and chemiluminescent detection was performed using Pierce Supersignal West Dura Maximum Sensitivity Substrate (Product # 37071). Relative density of the bands normalized to Lamin A/C (74/65 kDa). EP300 Antibody (Product # MA1-16608) confirms silencing of EP300 expression.
|Tested species reactivity||Human, Mustelid, Mouse, Non-human primate, Rat|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgG1, kappa|
|Immunogen||Fusion protein containing residues 1572-2371 of human p300.|
|Storage buffer||PBS, pH 7.4|
|Contains||0.1% sodium azide|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:250-1:500|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Western Blot (WB)||See 1 publications below|
Suggested positive control: HeLa nuclear extract.
p300 is a relatively stable, ubiquitously expressed, nuclear phosphoprotein which is conserved among a variety of mammalian species. It is actively synthesized and phosphorylated in both quiescent and proliferating cells.
Cyclic AMP-responsive enhancer binding protein (CREB) binding protein (CBP) and p300 are closely related transcriptional coactivators and have been shown to directly interact with many different DNA-binding transcription factors including nuclear hormone receptors, CREB, c-Fos, C-Jun/v-Jun, c-Myb/v-Myb, TFIIB and MyoD. Both CBP and p300 have been shown to display histone acetyltransferase (HAT) activity, capable of acetylating all four core histone particles in nucleosomes. As a result of HAT activity, it has been suggested CBP and p300 may play a direct role in activating chromatin for transcription.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53.
MA1-16608 was used in western blot to study the role of p53 in the interaction between simian virus 40 large T antigen and human CBP/p300
|Borger DR,DeCaprio JA||Journal of virology (80:4292)||2006|
Cyclic AMP responsive enhancer binding protein; E1A-associated protein p300; E1A-binding protein, 300kD; EP300: E1A binding protein p300; histone acetyltransferase p300; p300 HAT; RB and P300 binding protein EID 1
A430090G16; A730011L11; EP300; KAT3B; P300; p300 HAT; RSTS2